ESSA Pharma Inc.
NASDAQ:EPIX
5.74 (USD) • At close October 22, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -26.582 | -35.103 | -36.805 | -23.445 | -10.442 | -11.629 | -4.723 | -13.14 | -8.568 | -1.824 | -0.001 | -0.002 |
| Depreciation & Amortization
| 0.118 | 0.122 | 0.109 | 0.11 | 0.018 | 0.034 | 0.046 | 0.066 | 0.039 | 0.023 | 0 | 0 |
| Deferred Income Tax
| -0.672 | 0 | -0.107 | -0.156 | 0.015 | -0.048 | -7.335 | -6.714 | 0.024 | 0.043 | 0 | 0 |
| Stock Based Compensation
| 0.005 | 0.008 | 0.009 | 0.008 | 0.001 | 1.401 | 0.759 | 1.247 | 1.293 | 0.494 | 0 | 0 |
| Change In Working Capital
| 2.339 | -0.78 | 1.947 | -1.239 | -1.258 | -0.66 | -1.694 | 2.33 | 0.084 | 0.303 | 0 | -0 |
| Accounts Receivables
| -0.129 | 0.483 | -0.158 | 0.09 | -0.06 | -0.036 | -0.015 | 0.049 | -0.012 | -0 | 0 | -0 |
| Inventory
| 0 | 0 | 0.158 | -0.09 | 0.06 | 0 | 0 | 0 | -6.003 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 2.668 | -0.046 | -1.014 | -1.121 | -1.868 | 1.546 | 2.117 | 0.42 | 0 | 0 |
| Other Working Capital
| 2.468 | -1.263 | -0.721 | -1.192 | -0.244 | 0.461 | -1.694 | 2.33 | 3.982 | 0.303 | 0 | 0 |
| Other Non Cash Items
| 0.007 | -0.831 | -0.035 | 0.224 | -1.73 | 0.683 | -4.408 | 0.91 | -5.175 | -1.121 | 0 | 0 |
| Operating Cash Flow
| -19.782 | -28.704 | -25.416 | -16.983 | -12.25 | -10.218 | -17.355 | -15.301 | -12.302 | -2.081 | -0.001 | -0.002 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | -0.158 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | -0.247 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -365.204 | -296.012 | -57.026 | -22.011 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 361.677 | 242.959 | 22.011 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.004 | 0.705 | -0.035 | 0.274 | 0.201 | -0.201 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -3.527 | -52.348 | -35.015 | -21.737 | -0.046 | -0.201 | 0 | -0.01 | -0.158 | 0 | 0 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -0.137 | -0.134 | -0.1 | -4.007 | -2.809 | -1.991 | -7.779 | 0 | 0 | -0.001 | 0 | 0 |
| Common Stock Issued
| 0.069 | 0.387 | 150 | 48.99 | 36 | 26.04 | 0.003 | 20 | 11.601 | 2.183 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0 | -7.909 | -3.206 | 17.62 | -2.738 | 12.327 | 2.744 | -0.527 | 3.475 | 0 | 0.002 |
| Financing Cash Flow
| -0.068 | 0.253 | 141.991 | 41.777 | 50.811 | 21.31 | 12.327 | 22.744 | 11.074 | 5.659 | 0 | 0.002 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0.002 | 0.051 | -0.056 | -0.058 | -0.022 | -0.019 | 0 | -0.027 | -0.133 | -0.103 | 0 | 0 |
| Net Change In Cash
| -23.375 | -80.749 | 81.504 | 2.998 | 38.494 | 10.872 | -5.028 | 7.406 | -1.519 | 3.475 | -0.001 | 0.001 |
| Cash At End Of Period
| 33.702 | 57.076 | 137.825 | 56.321 | 53.323 | 14.829 | 3.957 | 8.985 | 1.57 | 3.7 | -0.001 | 0.001 |